Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Wigzell

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Nature|October 12, 2007
Science & Politics: when ministers are well primedHans Wigzell
Science (New York, N.Y.)|January 19, 2002
Science in Europe. Framework programmes evolveHans Wigzell
Science (New York, N.Y.)|March 19, 2005
A European CDC?Hans Wigzell
Science (New York, N.Y.)|September 7, 2002
Strengthening research in EuropeEnric Banda, Hans Wigzell, Ellis Rubinstein
Nature|February 17, 2017
George Klein (1925-2016)Ingemar Ernberg, Klas Kärre, Hans Wigzell
Current Opinion in Immunology|June 29, 2002
The role of IFN-gamma in the outcome of chlamydial infectionMartín E Rottenberg, Antonio Gigliotti-Rothfuchs, Hans Wigzell
Microbes and Infection|August 18, 2009
Use of non-invasive bioluminescent imaging to assess mycobacterial dissemination in mice, treatment with bactericidal drugs and protective immunityFrank Heuts, Berit Carow, Hans Wigzell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Intracellular bacterial infection-induced IFN-gamma is critically but not solely dependent on Toll-like receptor 4-myeloid differentiation factor 88-IFN-alpha beta-STAT1 signalingAntonio Gigliotti Rothfuchs, Christian Trumstedt, Hans Wigzell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2008
SOCS-1 protects against Chlamydia pneumoniae-induced lethal inflammation but hampers effective bacterial clearanceTangbin Yang, Patrik Stark, Katrin Janik, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2004
Macrophages, CD4+ or CD8+ cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFN-gammaAntonio Gigliotti Rothfuchs, Maria Regina Kreuger, Hans Wigzell, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Nature|October 12, 2007
Science & Politics: when ministers are well primedHans Wigzell
Science (New York, N.Y.)|January 19, 2002
Science in Europe. Framework programmes evolveHans Wigzell
Science (New York, N.Y.)|March 19, 2005
A European CDC?Hans Wigzell
Science (New York, N.Y.)|September 7, 2002
Strengthening research in EuropeEnric Banda, Hans Wigzell, Ellis Rubinstein
Nature|February 17, 2017
George Klein (1925-2016)Ingemar Ernberg, Klas Kärre, Hans Wigzell
Current Opinion in Immunology|June 29, 2002
The role of IFN-gamma in the outcome of chlamydial infectionMartín E Rottenberg, Antonio Gigliotti-Rothfuchs, Hans Wigzell
Microbes and Infection|August 18, 2009
Use of non-invasive bioluminescent imaging to assess mycobacterial dissemination in mice, treatment with bactericidal drugs and protective immunityFrank Heuts, Berit Carow, Hans Wigzell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Intracellular bacterial infection-induced IFN-gamma is critically but not solely dependent on Toll-like receptor 4-myeloid differentiation factor 88-IFN-alpha beta-STAT1 signalingAntonio Gigliotti Rothfuchs, Christian Trumstedt, Hans Wigzell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2008
SOCS-1 protects against Chlamydia pneumoniae-induced lethal inflammation but hampers effective bacterial clearanceTangbin Yang, Patrik Stark, Katrin Janik, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2004
Macrophages, CD4+ or CD8+ cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFN-gammaAntonio Gigliotti Rothfuchs, Maria Regina Kreuger, Hans Wigzell, et al.
Pageof 3